Biotechnology in Medicine
Recombinant insulin, gene therapy for ADA deficiency and molecular diagnosis. (Biology › Biotechnology and Its Applications, NEET UG syllabus.)
What is Biotechnology in Medicine?
Human insulin produced using recombinant DNA technology, typically by inserting human insulin genes into bacteria like *E. coli*.
Key points
- Explain the process of producing recombinant human insulin and its advantages.
- Describe the cause and symptoms of ADA deficiency and the gene therapy approach to treat it.
- Discuss the principles and applications of molecular diagnostic techniques like PCR and ELISA.
- Compare traditional diagnostic methods with molecular diagnostic methods.
Common exam trap
Confusing the role of C-peptide in natural insulin maturation vs. recombinant insulin production.
Definitions
- Term
Recombinant Insulin
- Meaning
Human insulin produced using recombinant DNA technology, typically by inserting human insulin genes into bacteria like *E. coli*.
- Term
Gene Therapy
- Meaning
A technique that involves introducing a functional gene into a patient's cells to correct a genetic defect or provide a new function.
- Term
Adenosine Deaminase (ADA) Deficiency
- Meaning
A genetic disorder caused by the deletion of the gene for ADA, leading to a dysfunctional immune system (Severe Combined Immunodeficiency - SCID).
- Term
Polymerase Chain Reaction (PCR)
- Meaning
A molecular biology technique used to amplify a specific segment of DNA across several orders of magnitude, generating thousands to millions of copies of a particular DNA sequence.
- Term
Enzyme-Linked Immunosorbent Assay (ELISA)
- Meaning
A plate-based assay technique designed for detecting and quantifying peptides, proteins, antibodies, and hormones based on antigen-antibody interactions.
- Term
Humulin
- Meaning
The brand name for the first human insulin produced using recombinant DNA technology by Eli Lilly.
Learning objectives
Explain the process of producing recombinant human insulin and its advantages.
Describe the cause and symptoms of ADA deficiency and the gene therapy approach to treat it.
Discuss the principles and applications of molecular diagnostic techniques like PCR and ELISA.
Compare traditional diagnostic methods with molecular diagnostic methods.
Appreciate the impact of biotechnology on modern medicine.
Prerequisites
Basic understanding of DNA structure and function.
Knowledge of gene expression (transcription, translation).
Concepts of genetic engineering and recombinant DNA technology (vectors, restriction enzymes, ligase).
Basic immunology (antigens, antibodies).
Understanding of genetic disorders.
Common mistakes
Confusing the role of C-peptide in natural insulin maturation vs. recombinant insulin production.
Believing gene therapy for ADA deficiency is a permanent cure with a single treatment (it often requires periodic infusions of genetically modified cells).
Misunderstanding the specific applications of PCR (DNA amplification) vs. ELISA (antigen-antibody detection).
Assuming all insulin used today is recombinant; some animal-derived insulin was used historically, but recombinant is now standard.
Not knowing the full form or significance of ADA and SCID.
Keywords
Recombinant DNA
Insulin
Humulin
Gene Therapy
ADA Deficiency
SCID
Molecular Diagnosis
PCR
ELISA
Retroviral Vector
Biopharmaceuticals
Practice preview
Adenosine Deaminase (ADA) deficiency leads to a severe combined immunodeficiency (SCID) due to the malfunctioning of which type of cells?…
easy
Why was the production of recombinant human insulin challenging, specifically regarding the formation of mature insulin from pro-insulin?…
medium
A patient is suspected of having an early-stage HIV infection. Which molecular diagnostic technique would be most effective for confirming the diagnosis before the appearance of clinical symptoms?…
medium